Literature DB >> 9723999

Experimental short-term tolerance to perfluorodecalin in the rabbit eye: a histopathological study.

N Orzalesi1, L Migliavacca, F Bottoni, S Miglior.   

Abstract

PURPOSE: Perfluorocarbon liquids are largely used in vitreoretinal surgery, but their permanence into the eye is considered harmful and early withdrawal is routinely performed by most of the surgeons. We undertook this investigation to evaluate the effects of Perfluorodecalin (PFD) tamponade following vitrectomy in the rabbit eye.
METHODS: Twenty-four rabbits underwent vitrectomy of the right eye according with a standard procedure. Eighteen rabbits received PFD and 6 control rabbits received Balanced Salt Solution (BSS) as vitreous substitute. The eyes were examined with light microscopy and transmission electron microscopy after two, four and six days after tamponade and thirty days after the withdrawal of PFD.
RESULTS: The tamponade lasting four or more days caused irreversible retinal damage involving the photoreceptors and retinal pigment epithelium. Peculiar impressions were formed in the inner retina at the site of the gravitational effect of PFD droplets.
CONCLUSIONS: Based on the results of this study we suggest that the tamponade with PFD lasting more than two days is detrimental to the retina, at least in the case of the rabbit. Damage seems to be related only to the high specific gravity of PFD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723999     DOI: 10.1076/ceyr.17.8.828.5157

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Management of inferior retinal breaks during pars plana vitrectomy for retinal detachment.

Authors:  V Tanner; M Minihan; T H Williamson
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Vitreal oxygenation in retinal ischemia reperfusion.

Authors:  Walid Abdallah; Hossein Ameri; Ernesto Barron; Gerald J Chader; Elias Greenbaum; David R Hinton; Mark S Humayun
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

3.  The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.

Authors:  Stanislao Rizzo; Federica Genovesi-Ebert; Claudia Belting
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-21       Impact factor: 3.117

4.  Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes.

Authors:  Jerzy Mackiewicz; Kristel Maaijwee; Christoph Lüke; Norbert Kociok; Wilfried Hiebl; Hasso Meinert; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-11       Impact factor: 3.535

5.  Ocular tolerance and efficacy of short-term tamponade with double filling of polydimethyloxane and perfluoro-n-octane.

Authors:  Stefano Zenoni; Mario R Romano; Sonia Palmieri; Natalia Comi; Edoardo Fiorentini; Piero Fontana
Journal:  Clin Ophthalmol       Date:  2011-04-06

6.  Repeated subretinal surgery and removal of subretinal decalin is well tolerated - evidence from a porcine model.

Authors:  Nina Buus Sørensen; Kristian Klemp; Troels Wesenberg Kjær; Steffen Heegaard; Morten la Cour; Jens Folke Kiilgaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-12       Impact factor: 3.117

Review 7.  Vitreous Substitutes as Drug Release Systems.

Authors:  André Schulz; Peter Szurman
Journal:  Transl Vis Sci Technol       Date:  2022-09-01       Impact factor: 3.048

8.  A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.

Authors:  Songfu Feng; Han Chen; Yaqin Liu; Zhen Huang; Xuyuan Sun; Lian Zhou; Xiaohe Lu; Qianying Gao
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 9.  Vitreous substitutes: the present and the future.

Authors:  Simone Donati; Simona Maria Caprani; Giulia Airaghi; Riccardo Vinciguerra; Luigi Bartalena; Francesco Testa; Cesare Mariotti; Giovanni Porta; Francesca Simonelli; Claudio Azzolini
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.